Professor | Zhiwei Wu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Zhiwei Wu
Contact Information	wzhw@nju.edu.cn
Language ability	English, Chinese
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Zhiwei Wu

Contact Information

wzhw@nju.edu.cn

Language ability

English, Chinese

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	1982 - Bachelor's Degree: Nanjing University 1991 - Ph.D.: University of Edinburgh 2006 - Established Public Health Medicine Center at Nanjing University
Work Experience	1990-1997 - Postdoctoral Training: New York University 1997-2006 - Assistant Professor and Senior Researcher: Rockefeller University and University of Pennsylvania 2006-Present - Professor and Director: Public Health Medicine Center, Nanjing University
Awards	Jiangsu Province Science and Technology Progress Award (Year Not Mentioned): Basic and Clinical Research on Severe Hand, Foot, and Mouth Disease Caused by EV71 Infection

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

1982 - Bachelor's Degree: Nanjing University
1991 - Ph.D.: University of Edinburgh
2006 - Established Public Health Medicine Center at Nanjing University

Work Experience

1990-1997 - Postdoctoral Training: New York University
1997-2006 - Assistant Professor and Senior Researcher: Rockefeller University and University of Pennsylvania
2006-Present - Professor and Director: Public Health Medicine Center, Nanjing University

Awards

Jiangsu Province Science and Technology Progress Award (Year Not Mentioned): Basic and Clinical Research on Severe Hand, Foot, and Mouth Disease Caused by EV71 Infection

Areas of Focus	Virus Infection and Immunity Vaccine and Antiviral Drug Development Extracellular Vesicles and Virus Pathology RNA Virus and Host Cell Interaction Nanobody Development for Virus Inhibition Rapid Immunodiagnostic Reagents
Publications	Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection, Yuxuan Fu, Li Zhang, Fang Zhang, Ting Tang, Chunhong Feng, Yu Jin, Zhiwei Wu, 2017 Deficient humoral response and disrupted B cell immunity are associated with fatal SFTSV infection, Peixin Song, Nan Zheng, Yong Liu, Chen Tian, Xilin Wu, Xiaohua Ma, Deyan Chen, Xue Zou, Guiyang Wang, Huanru Wang, Yongyang Zhang, Sufang Lu, Chao Wu, Zhiwei Wu, 2018 Development of a potent neutralizing nanobody as therapeutics against SFTSV infection, Xilin Wu, Yanlei Li, Xiaohua Ma, Linjing Zhu, Bilian Huang, Nan Zheng, Shijie Xu, Waqas Nawaz, Zhiwei Wu, 2020 Extracellular vesicles containing host restriction factor IFITM3 inhibited Zika virus infection of fetuses in pregnant mice through trans-placenta delivery, Xue Zou, Meng Yuan, Yutong Zhang, Nan Zheng, Zhiwei Wu, 2021 NanoTech and Immunoengineering: How nanotech can boost CAR-T therapy, Waqas Nawaz, Shijie Xu, Yanlei Li, Bilian Huang, Xilin Wu, Zhiwei Wu, 2020 The power of imaging to understand EV biology in vivo, Frederik J. Verweij, Leonora Balaj, Chantal Boulanger, David RF Carter, Ewaldus B Compeer, Gisela D’Angelo G, Samir El Andaloussi, Jacky G. Goetz, Julia Groß, Vincent Hyenne, Eva-Maria Krämer-Albers A, Charles Lai, Xavier Loyer, Alex Marki, Stefan Momma, Esther Nolte ‘t Hoen, Michiel D Pegtel, Hector Peinado, Graça Raposo, Kirsi Rilla, Hidetoshi Tahara, Clotilde Théry, Martin Van Royen, Roosmarijn Vandenbroecke, Ann Wehman, Kenneth Witwer, Zhiwei Wu, Richard Wubbolts, Guillaume van Niel, 2021 AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia, Waqas Nawaz, Bilian Huang, Shijie Xu, Yanlei Li, Linjing Zhu, Hu Yiqiao, Zhiwei Wu, Xilin Wu, 2021 Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome, Shijie Xu, Na Jiang, Waqas Nawaz, Bingxin Liu, Fang Zhang, Ye Liu, Xilin Wu, Zhiwei Wu, 2021 Nonstructural protein NSs hampers cellular antiviral response through LSm14A during Severe Fever with Thrombocytopenia Syndrome Virus Infection, Li Zhang, Yuxuan Fu, Rui Zhang, Yajie Guan, Na Jiang, Nan Zheng, Zhiwei Wu, 2021 Potent bispecific nanobody provides in vivo protection against SARS-CoV-2 via intranasal administration, Xilin Wu, Lin Cheng, Ming Fu, Bilian Huang, Yalan Liu, Linjing Zhu, Shijie Xu, Haixia Shi, Doudou Zhang, Huanyun Yuan, Waqas Nawaz, Ping Yang, Qinxue Hu, Zhiwei Wu, 2021

Areas of Focus

Virus Infection and Immunity
Vaccine and Antiviral Drug Development
Extracellular Vesicles and Virus Pathology
RNA Virus and Host Cell Interaction
Nanobody Development for Virus Inhibition
Rapid Immunodiagnostic Reagents

Publications

Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection, Yuxuan Fu, Li Zhang, Fang Zhang, Ting Tang, Chunhong Feng, Yu Jin, Zhiwei Wu, 2017
Deficient humoral response and disrupted B cell immunity are associated with fatal SFTSV infection, Peixin Song, Nan Zheng, Yong Liu, Chen Tian, Xilin Wu, Xiaohua Ma, Deyan Chen, Xue Zou, Guiyang Wang, Huanru Wang, Yongyang Zhang, Sufang Lu, Chao Wu, Zhiwei Wu, 2018
Development of a potent neutralizing nanobody as therapeutics against SFTSV infection, Xilin Wu, Yanlei Li, Xiaohua Ma, Linjing Zhu, Bilian Huang, Nan Zheng, Shijie Xu, Waqas Nawaz, Zhiwei Wu, 2020
Extracellular vesicles containing host restriction factor IFITM3 inhibited Zika virus infection of fetuses in pregnant mice through trans-placenta delivery, Xue Zou, Meng Yuan, Yutong Zhang, Nan Zheng, Zhiwei Wu, 2021
NanoTech and Immunoengineering: How nanotech can boost CAR-T therapy, Waqas Nawaz, Shijie Xu, Yanlei Li, Bilian Huang, Xilin Wu, Zhiwei Wu, 2020
The power of imaging to understand EV biology in vivo, Frederik J. Verweij, Leonora Balaj, Chantal Boulanger, David RF Carter, Ewaldus B Compeer, Gisela D’Angelo G, Samir El Andaloussi, Jacky G. Goetz, Julia Groß, Vincent Hyenne, Eva-Maria Krämer-Albers A, Charles Lai, Xavier Loyer, Alex Marki, Stefan Momma, Esther Nolte ‘t Hoen, Michiel D Pegtel, Hector Peinado, Graça Raposo, Kirsi Rilla, Hidetoshi Tahara, Clotilde Théry, Martin Van Royen, Roosmarijn Vandenbroecke, Ann Wehman, Kenneth Witwer, Zhiwei Wu, Richard Wubbolts, Guillaume van Niel, 2021
AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia, Waqas Nawaz, Bilian Huang, Shijie Xu, Yanlei Li, Linjing Zhu, Hu Yiqiao, Zhiwei Wu, Xilin Wu, 2021
Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome, Shijie Xu, Na Jiang, Waqas Nawaz, Bingxin Liu, Fang Zhang, Ye Liu, Xilin Wu, Zhiwei Wu, 2021
Nonstructural protein NSs hampers cellular antiviral response through LSm14A during Severe Fever with Thrombocytopenia Syndrome Virus Infection, Li Zhang, Yuxuan Fu, Rui Zhang, Yajie Guan, Na Jiang, Nan Zheng, Zhiwei Wu, 2021
Potent bispecific nanobody provides in vivo protection against SARS-CoV-2 via intranasal administration, Xilin Wu, Lin Cheng, Ming Fu, Bilian Huang, Yalan Liu, Linjing Zhu, Shijie Xu, Haixia Shi, Doudou Zhang, Huanyun Yuan, Waqas Nawaz, Ping Yang, Qinxue Hu, Zhiwei Wu, 2021

Virus Immunity Vaccine Antiviral Extracellular Vesicles Pathology Rna Virus Host Interaction Nanobody Immunodiagnostic

Lian Huan - Wuhan University

Lei Sun - University of Chinese Academy of Sciences

Tao Deng - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us